Skip to NavigationSkip to content

News

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of Chicago,...
A drug’s work is never done when it comes to snagging more indications but Roche have hit a stumbling block in metastatic colorectal cancer (mCRC),...
A partnership of the not-for-profit organisation Drugs for Neglected Diseases initiative and Egyptian drug firm Pharco Pharmaceuticals is working...
The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding the use of...
One of the major stumbling blocks that science has come up against in Alzheimer's is that promising trials results in mice have not translated so...
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, according to the company, is...
Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with women how had the device...
AbbVie's upadacitinib smashed met its primary and secondaery endpoints at Phase 3 in the treatment of moderate to severe rheumatoid arthritis in...
Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches